CRP and Hypertension: They also exhibited higher hypertension prevalence (39.71% vs. 30.44%), greater functional limitation (42.34% vs. 28.28%), and elevated biomarker levels, including systolic blood pressure (132.30 ± 23.80 vs. 126.70 ± 20.07 mmHg) and C-reactive protein [2.93 (IQR 2.25–3.61) vs. 2.55 (2.26–2.83) mg/dL], compared to their counterparts without sarcopenic at baseline (all P < 0.05; Table 1).